Literature DB >> 6118605

Disodium azodisalicylate in ulcerative colitis.

D P Jewell, S C Truelove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6118605     DOI： 10.1016/s0140-6736(81)90616-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

2.  Olsalazine in maintenance of clinical remission in patients with ulcerative colitis.

Authors:  J P Wright; E A O'Keefe; L Cuming; K Jaskiewicz
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

3.  Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Authors:  R P Chan; D J Pope; A P Gilbert; P J Sacra; J H Baron; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

4.  Olsalazine in active ulcerative colitis.

Authors:  W S Selby; G D Barr; A Ireland; C H Mason; D P Jewell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.